Fernanda Motta R. da Silva

Fernanda Motta R. da Silva

Auto-generated profile, based on publicly available information

Fernanda Motta R. da Silva

Laboratory of Molecular Pharmacology, Institute of Biomedical Sciences, Federal University of Rio de Janeiro, RJ 21941-902, Brazil

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
LLLaís Flávia Nunes Lemes
Laís Flávia Nunes Lemes
GRGiselle de Andrade Ramos
Giselle de Andrade Ramos
AOAndressa Souza de Oliveira
Andressa Souza de Oliveira
FSFernanda Motta R. da Silva
Fernanda Motta R. da Silva
GCGina de Castro Couto
Gina de Castro Couto
LRLuiz Romeiro
Luiz Romeiro

1 April 2017 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
KDKris Simone T. Dias
Kris Simone T. Dias
CPCynthia T. de Paula
Cynthia T. de Paula
TSThiago dos Santos
Thiago dos Santos
ISIsis Nem de Oliveira Souza
Isis Nem de Oliveira Souza
MBMarina S. Boni
Marina S. Boni
CJClaudio Viegas Jr.
Claudio Viegas Jr.

1 March 2018 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
FVFlávia Pereira Dias Viegas
Flávia Pereira Dias Viegas
MSMatheus de Freitas Silva
Matheus de Freitas Silva
MRMiguel Divino da Rocha
Miguel Divino da Rocha
MCMaísa Rosa Castelli
Maísa Rosa Castelli
MRMariana Máximo Riquiel
Mariana Máximo Riquiel
CJClaudio Viegas Jr.
Claudio Viegas Jr.

1 November 2015 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
EPElaine da Conceição Petronilho
Elaine da Conceição Petronilho
MRMagdalena Do Nascimento Rennó
Magdalena Do Nascimento Rennó
NCNewton G Castro
Newton G Castro
FSFernanda Motta R. da Silva
Fernanda Motta R. da Silva
APAngelo da Cunha Pinto
Angelo da Cunha Pinto
JFJosé D. Figueroa-Villar
José D. Figueroa-Villar
Analogs of pralidoxime, which is a commercial antidote for intoxication from neurotoxic organophosphorus compounds, were designed, synthesized, characterized, and tested as potential inhibitors or reactivators of acetylcholinesterase (AChE) using the Ellman’s test, nuclear magnetic resonance, and molecular modeling. These analogs include 1-methylpyridine-2-carboxaldehyde hydrazone, 1-methylpyridine-2-carboxaldehyde guanylhydrazone, and six other guanylhydrazones obtained from different benzaldehydes. The results indicate that all compounds are weak AChE reactivators but relatively good AChE inhibitors. The most effective AChE inhibitor discovered was the guanylhydrazone derived from 2,4-dinitrobenzaldehyde and was compared with tacrine, displaying similar activity to this reference material. These results indicate that guanylhydrazones as well as future similar derivatives may function as drugs for the treatment of Alzheimer's disease.